As of 2025-10-29, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 17.0x | 15.6x |
| Forward P/E multiples | 15.7x - 16.5x | 15.9x |
| Fair Price | (10.70) - (11.00) | (10.73) |
| Upside | -170.1% - -172.2% | -170.3% |
| Date | EV/EBITDA |